Does Q32 Bio (QTTB) Have the Potential to Rally 97.66% as Wall Street Analysts Expect?

Core Viewpoint - Q32 Bio (QTTB) shares have increased by 59% in the past four weeks, closing at $7.25, with a potential upside of 97.7% based on Wall Street analysts' mean price target of $14.33 [1] Price Targets - The average price target consists of three estimates ranging from a low of $10.00 to a high of $20.00, with a standard deviation of $5.13, indicating variability among analysts [2] - The lowest estimate suggests a 37.9% increase from the current price, while the highest estimate indicates a 175.9% upside [2] Analyst Sentiment - Analysts are optimistic about QTTB's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which historically correlate with stock price movements [4][11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has risen by 22.1%, with two estimates moving higher and no negative revisions [12] Zacks Rank - QTTB holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, suggesting strong potential for near-term upside [13] Conclusion on Price Targets - While consensus price targets may not be reliable for predicting exact stock gains, they can provide a directional guide for potential price movements [14]